Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yadi Zhou

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Aging Cell|January 13, 2022
Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patientsYuan Hou, Yadi Zhou, Lara Jehi, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentYadi Zhou, Jielin Xu, Yuan Hou, et al.
Ebiomedicine|September 19, 2019
RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cellsLili Yao, Yadi Zhou, Zhenhua Sui, et al.
Nature Aging|May 16, 2022
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's diseaseJiansong Fang, Pengyue Zhang, Yadi Zhou, et al.
Biochemical Pharmacology|January 10, 2025
Guggulsterone ameliorates psoriasis by inhibiting keratinocyte proliferation and inflammation through induction of miR-17 directly targeting JAK1 and STAT3Lu Xiang, Yangli Shen, Shuangteng Liu, et al.
Alzheimer'S Research & Therapy|June 10, 2021
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentYadi Zhou, Jielin Xu, Yuan Hou, et al.
Journal of Chemical Information and Modeling|February 16, 2012
In silico assessment of chemical biodegradabilityFeixiong Cheng, Yutaka Ikenaga, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 31, 2025
Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulationReina Tonegawa-Kuji, Ehud Karavani, Michael Danziger, et al.
Signal Transduction and Targeted Therapy|July 31, 2021
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19Yuan Hou, Yadi Zhou, Michaela U Gack, et al.
Brain : a Journal of Neurology|June 23, 2020
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjectsLisa-Marie Niestroj, Eduardo Perez-Palma, Daniel P Howrigan, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Aging Cell|January 13, 2022
Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patientsYuan Hou, Yadi Zhou, Lara Jehi, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentYadi Zhou, Jielin Xu, Yuan Hou, et al.
Ebiomedicine|September 19, 2019
RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cellsLili Yao, Yadi Zhou, Zhenhua Sui, et al.
Nature Aging|May 16, 2022
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's diseaseJiansong Fang, Pengyue Zhang, Yadi Zhou, et al.
Biochemical Pharmacology|January 10, 2025
Guggulsterone ameliorates psoriasis by inhibiting keratinocyte proliferation and inflammation through induction of miR-17 directly targeting JAK1 and STAT3Lu Xiang, Yangli Shen, Shuangteng Liu, et al.
Alzheimer'S Research & Therapy|June 10, 2021
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairmentYadi Zhou, Jielin Xu, Yuan Hou, et al.
Journal of Chemical Information and Modeling|February 16, 2012
In silico assessment of chemical biodegradabilityFeixiong Cheng, Yutaka Ikenaga, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 31, 2025
Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulationReina Tonegawa-Kuji, Ehud Karavani, Michael Danziger, et al.
Signal Transduction and Targeted Therapy|July 31, 2021
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19Yuan Hou, Yadi Zhou, Michaela U Gack, et al.
Brain : a Journal of Neurology|June 23, 2020
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjectsLisa-Marie Niestroj, Eduardo Perez-Palma, Daniel P Howrigan, et al.
Pageof 9